DIONEX CORP /DE
10-Q, 1998-05-15
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Previous: PRINCETON NATIONAL BANCORP INC, 10-Q, 1998-05-15
Next: GRAHAM FIELD HEALTH PRODUCTS INC, 10-Q, 1998-05-15



                       						    This document consists of 15
                       						    pages, of which this page
                       						    is number 1.



FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
- -------------------------------

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended March 31, 1998

OR

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934 

	Commission File Number 0-11250 

                  DIONEX CORPORATION				
     (Exact name of registrant as specified in its charter)    

          Delaware                    94-2647429	   
(State or other jurisdiction of     (I.R.S. Employer
 incorporation or organization)     Identification No.)  

1228 Titan Way, Sunnyvale, California  		       94086		   
(Address of principal executive offices)	    (Zip Code)

Registrant's telephone number, including area code (408) 737-0700

                                 NONE						                        
(Former name, former address and former fiscal year, if changed
since last report.)

Indicate by check mark whether the registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.

                                        YES   X    NO_____

Indicate the number of shares outstanding of each of the issuer's 
classes of common stock, as of May 11, 1998:

	        CLASS                    NUMBER OF SHARES

     Common Stock                    11,261,330

<PAGE>
DIONEX CORPORATION
INDEX


PART I.  FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS                      		     Page 

       CONDENSED CONSOLIDATED BALANCE SHEETS
       March 31, 1998 and June 30, 1997..................   3

       CONDENSED CONSOLIDATED STATEMENTS OF INCOME
       Three Months Ended March 31, 1998 and 1997........   4

       CONDENSED CONSOLIDATED STATEMENTS OF INCOME
       Nine Months Ended March 31, 1998 and 1997.........   5

       CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
       Nine Months Ended March 31, 1998 and 1997.........  6-7

       NOTES TO CONDENSED CONSOLIDATED FINANCIAL
       STATEMENTS........................................ 8-10


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
         CONDITION AND RESULTS OF OPERATIONS............. 10-14


PART II.  OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K................   15

SIGNATURES...............................................   15






















2
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
- -------------

                                                   March 31,   June 30,
         ASSETS                                      1998	       1997
                                                  (unaudited)
Current assets:
  Cash and equivalents (including invested cash
    of $10,079 at March 31, 1998 and $16,586
    at June 30, 1997)............................  $ 19,004   $ 24,624
  Temporary cash investments.....................     4,850      8,252
  Accounts receivable (net of allowance for    
    doubtful accounts of $548 at March 31,1998
    and $533 at June 30, 1997)...................    31,104     29,226
  Inventories....................................     9,771      9,479
  Deferred taxes.................................     7,651      7,136
  Prepaid expenses and other.....................     1,763      1,076
         Total current assets....................    74,143     79,793

Property, plant and equipment, net...............    29,434     30,225
Other assets ....................................     8,771      8,145  
                                      			   	      $112,348   $118,163

	LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Notes payable to banks.........................  $    750   $    -  
  Accounts payable...............................     4,557      4,442
  Accrued liabilities............................    16,714     18,639
  Income taxes payable...........................     5,655      4,905
  Accrued product warranty.......................     3,810      3,592
         Total current liabilities...............    31,486     31,578

Deferred taxes...................................     2,689      2,422
Stockholders' equity:
  Preferred stock (par value $.001 per share;
    1,000,000 shares authorized; none
    outstanding).................................        -         -
  Common stock (par value $.001 per share;
    40,000,000 shares authorized; outstanding:
    11,388,583 shares at March 31, 1998 and   
    11,847,030 shares at June 30, 1997)..........    39,244     36,323
  Retained earnings..............................    38,501     46,622
  Accumulated translation adjustments............    (2,188)      (996)
  Net unrealized gain on securities..............     2,616      2,214  
         Total stockholders' equity..............    78,173     84,163
                                                   $112,348   $118,163




See notes to condensed consolidated financial statements. 


3
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
THREE MONTHS ENDED MARCH 31, 1998 AND 1997
(In thousands, except per share amounts)
- ------------------



                                                     1998     1997
                                                      (unaudited)

Net sales......................................    $38,404  $36,646
Cost of sales..................................     12,134   11,044

Gross profit...................................     26,270   25,602

Operating expenses:
  Selling, general and administrative..........     11,706   11,784
  Research and product development.............      3,471    3,397

     Total operating expenses..................     15,177   15,181

Operating income...............................     11,093   10,421
 
Interest income................................        325      310 
Interest expense...............................        (27)     (18)

Income before taxes on income..................     11,391   10,713
Taxes on income................................      3,873    3,697

Net income.....................................    $ 7,518  $ 7,016

Basic earnings per share.......................    $   .66  $   .59

Diluted earnings per share.....................    $   .62  $   .55

Shares used in computing per share amounts:

     Basic.....................................     11,403   11,946

     Diluted...................................     12,089   12,644












 See notes to condensed consolidated financial statements.               


4
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
NINE MONTHS ENDED MARCH 31, 1998 AND 1997
(In thousands, except per share amounts)
- ------------------


                                                   1998      1997
                                                    (unaudited)   

Net sales.....................................  $111,757  $104,754
Cost of sales.................................    35,254    31,782 

Gross profit..................................    76,503    72,972 

Operating expenses:
  Selling, general and administrative.........    35,617    35,549
  Research and product development............     9,896     9,271

     Total operating expenses.................    45,513    44,820

Operating income..............................    30,990    28,152

Interest income...............................     1,065     1,022 
Interest expense..............................       (81)      (66)

Income before taxes on income.................    31,974    29,108
Taxes on income...............................    10,871    10,043

Net income....................................  $ 21,103  $ 19,065


Basic earnings per share......................  $   1.83  $   1.58

Diluted earnings per share....................  $   1.72  $   1.49

Shares used in computing per share amounts:

  Basic.......................................    11,560    12,102

  Diluted.....................................    12,245    12,754










 See notes to condensed consolidated financial statements.               



5
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE MONTHS ENDED MARCH 31, 1998 AND 1997
(In thousands)
- ------------------

                                                        1998      1997
                                       		                (unaudited)
Cash and equivalents provided by (used for):

Cash flows from operating activities:
Net income............................................$21,103   $19,065
Adjustments to reconcile net income to net cash
  provided by operating activities:
  Depreciation and amortization.......................  1,892	    1,886
  Deferred taxes......................................   (516)     (517)
 
  Changes in assets and liabilities:
    Accounts receivable...............................	(3,800)   (3,278)
    Inventories.......................................	  (736)   (1,126)
    Prepaid expenses and other assets.................	  (758)       98
    Accounts payable..................................	   222       963
    Accrued liabilities...............................	(1,680)   (1,298)
    Income taxes payable..............................	   817       720
    Accrued product warranty..........................	   259       478
Net cash provided by operating activities.............	16,803    16,991

Cash flows from investing activities:
  Purchase of temporary cash investments..............(11,000)  (14,600)
  Proceeds from maturities of temporary
     cash investments................................. 14,402    24,899
  Purchase of property, plant and equipment........... (1,266)   (2,150)
  Other...............................................    (81)     (124)
Net cash provided by investing activities.............  2,055     8,025

Cash flows from financing activities:
  Net change in notes payable to banks................	   750     1,044
  Sale of common stock................................	 4,900     5,212
  Repurchase of common stock..........................(31,203)  (25,599)
  Other...............................................     19        21
Net cash used for financing activities................(25,534)  (19,322)

Effect of exchange rate changes on cash...............	 1,056       910

Net increase(decrease)in cash and equivalents........	 (5,620)    6,604
Cash and equivalents, beginning of period............. 24,624	   16,986

Cash and equivalents, end of period...................$19,004   $23,590
(continued)






6
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE MONTHS ENDED MARCH 31, 1998 AND 1997
(In thousands)
- ------------------


                                                   1998     1997
                                		                  (unaudited)
(continued)
Supplemental disclosures of cash flow information:
  Income taxes paid..............................	$ 8,610  $ 8,199
  Interest paid.................................. $    79  $    64



































See notes to condensed consolidated financial statements.                








7
<PAGE>
DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
- ------------------



1.  Basis of Presentation

    The condensed consolidated financial statements included
    herein have been prepared by the Company, without audit,
    pursuant to the rules and regulations of the Securities and
    Exchange Commission.  Certain information and footnote
    disclosures normally included in financial statements
    prepared in accordance with generally accepted accounting
    principles have been condensed or omitted pursuant to such
    rules and regulations, although the Company believes the
    disclosures which are made are adequate to make the
    information presented not misleading.  It is suggested that
    these condensed consolidated financial statements be read
    in conjunction with the consolidated financial statements
    and the notes thereto included in the Company's Annual
    Report to Stockholders for the fiscal year ended
    June 30, 1997. 

    The unaudited condensed consolidated financial statements
    included herein reflect all adjustments (which include only
    normal, recurring adjustments) which are, in the opinion of
    management, necessary to state fairly the results for the
    periods presented.  The results for such periods are not
    necessarily indicative of the results to be expected for
    the entire fiscal year ending June 30, 1998.

2.  Inventories

    Inventories consist of (in thousands):
				     								
                                      March 31,	      June 30,
                                        1998           1997	  

      Finished goods                   $3,622 	       $3,720
      Work in process                   3,561          2,584
      Raw materials and subassemblies   2,588          3,175

                                       $9,771         $9,479

3.   Income Taxes

     The effective income tax rate for the first nine months of
     fiscal 1998 was 34.0%, down slightly from the 34.5% reported
     in the same period of fiscal 1997.






8
<PAGE>
DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
- ------------------



4.   Earnings Per Share
 
     In February 1997, the Financial Accounting Standards Board
     issued SFAS No. 128, Earnings Per Share.  The Company 
     adopted SFAS No. 128 in the second quarter of fiscal 1998
     and restated earnings per share data for prior periods to
     conform with the current presentation.  SFAS No. 128
     requires a dual presentation of basic and diluted earnings
     per share (EPS).

     Basic earnings per share excludes dilution and is computed
     by dividing net income by the weighted average of common
     shares outstanding for the period.  Diluted earnings per
     share reflects the potential dilution from securities and
     other contracts which are exercisable or convertible into
     common stock.  Diluted earnings per share is computed by
     dividing net income by the weighted average number of common
     shares that would have been outstanding during the period
     assuming the issuance of common shares for all dilutive
     potential common shares outstanding.  For the Company, the
     difference between the number of shares outstanding for
     basic and diluted earnings per share is due to stock options
     outstanding during the period.  
	
5.   Recently Issued Accounting Standards

     During June 1997, the Financial Accounting Standards Board 
     (Board) issued Statement of Financial Accounting Standards 
     No. 130, Reporting Comprehensive Income (SFAS 130), which 
     requires that the Company report comprehensive income in the 
     financial statements, in addition to net income.  For the 
     Company, the primary differences between net income and 
     comprehensive income will be foreign currency translation 
     adjustments and changes in net unrealized gains on 
     securities available for sale. The Board also issued 
     Statements of Financial Accounting Standards No. 131, 
     Disclosures about Segments of an Enterprise and Related 
     Information (SFAS 131), which establishes annual and 
     interim reporting standards for an enterprise's operating 
     segments.  It also establishes standards for related 
     disclosures about products, services, geographic areas, and 
     major customers.  Adoption of these statements will not 
     impact the Company's consolidated financial position, 
     results of operations or cash flows, and any effect will be 
     limited to the form and content of its disclosures.  Both 
     statements are effective for fiscal years beginning after 
     December 15, 1997, with earlier application permitted. 



9
<PAGE>
DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
- ------------------



 6.  Common Stock Repurchases

     During the first nine months of fiscal 1998, the Company
     repurchased 633,225 shares of its common stock on the open
     market compared with 679,450 shares repurchased in the
     first nine months of the previous fiscal year.  During all
     of fiscal 1997, the Company repurchased 791,739 shares.











































10
<PAGE>
DIONEX CORPORATION


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
    	    CONDITION AND RESULTS OF OPERATIONS

Results of Operations - Three Months Ended March 31, 1998
and 1997

Net sales for the three months ended March 31, 1998 were $38.4 
million, an increase of 5% from the $36.6 million reported for 
the same period last year.  The Company experienced sales growth 
in its North American and European markets.  Sales in our Asian 
markets were lower due to the financial turmoil which created 
economic uncertainty.  Had currency rates been the same as in the 
third quarter of last year, sales growth would have been 9%.  

Gross margin for the third quarter of fiscal 1998 was 68.4%, 
compared with the 69.9% reported in the same period last year.  
The reduction in gross margin was due primarily to an unfavorable 
effect of currency fluctuations and higher product costs.  There 
were no significant selling price changes between these periods.  

Operating expenses of $15.2 million for the third quarter of 
fiscal 1998 were unchanged from the prior year.  As a percentage 
of sales, operating expenses in the current quarter were 40% 
compared with 41% for the same period last year.  

Selling, general and administrative expenses decreased $78,000, 
or 1%, to $11.7 million in the three months ended March 31, 1998.  
The decrease was mainly due to the favorable effect of currency 
fluctuations on international selling expenses.

Research and development (R&D) costs of $3.5 million increased 
$74,000, or 2%, compared with the same period last year.  The 
level of R&D spending varies depending on both the breadth of the 
Company's R&D efforts and the stage of specific product 
development. 

Interest income of $325,000 for the three months ended March 31, 
1998 was essentially unchanged from the $310,000 reported for the 
third quarter last year.

The effective tax rate for the third quarter of fiscal 1998 was 
34.0%, compared with 34.5% for the same period last year.  
Variations in the tax rate reflect changes in the mix of taxable 
income among the various tax jurisdictions in which the Company 
does business.  The effective tax rate for the remainder of 
fiscal 1998 is expected to be consistent with the first nine 
months of fiscal 1998.  






11 
<PAGE>
Net income in the third quarter of fiscal 1998 was $7.5 million, 
an increase of 7% from the $7.0 million reported in the third 
quarter last year.  Basic earnings per share of $.66 increased 
$.07, or 12%, compared with $.59 per share last year.  Diluted 
earnings per share increased by $.07 per share, or 13%, to $.62 
compared with $.55 reported for the third quarter last year.  
Basic and diluted earnings per share were favorably affected by 
the Company's stock repurchase program.

Results of operations - Nine Months Ended March 31, 1998
and 1997

Net sales for the nine months were $111.8 million, an increase of 
7% over the $104.8 million reported for the same period last 
year.  The increase in sales was attributable to growth in North 
America and a continued strengthening in Europe.  Business in our 
Asian markets was weak due to the financial uncertainties in that 
area.  Currency fluctuations had an unfavorable effect on sales 
growth in the nine-month period.  Had currency rates remained the 
same as the first nine months of last year, sales growth would 
have been 12%.

Gross margin in the first nine months of fiscal 1998 was 68.5%, 
down 1.2% from the 69.7% reported in the first nine months of 
fiscal 1997.  The decline in gross margin is attributable to an 
unfavorable effect of currency fluctuations and higher product 
costs.  There were no significant selling price changes between 
these periods.

Operating expenses of $45.5 million for the first nine months of  
fiscal 1998 increased less than 2% from the $44.8 million 
reported for the first nine months last year.  Operating expenses 
as a percentage of sales decreased to 41% from the 43% of sales 
reported last year.  

SG&A expenses for the first nine months of fiscal 1998 increased 
less than 1%, from $35.5 million to $35.6 million.  Increases in 
personnel and related costs, were partially offset by the effect 
of currency fluctuations on international selling expenses.  SG&A 
expenses were 32% of sales for the first nine months of fiscal 
1998 compared with 34% for the same period last year.  

R&D expenses for the first nine months were $9.9 million, an 
increase of $625,000, or 7%, from the $9.3 million reported for 
the same period last year.  The increased costs were primarily 
attributable to personnel and related costs and project 
materials.  The level of R&D spending varies depending on both 
the breadth of the Company's R&D efforts and the stage of 
specific product development.

Interest income for the first nine months of fiscal 1998 was up
slightly to $1.1 million from $1.0 million reported for the same 
period last year.  




12
<PAGE>
The effective income tax rate was 34.0% in the first three 
quarters of fiscal 1998, compared to 34.5% in the prior year's 
first three quarters.  Variations in the tax rate reflect 
variations in the mix of taxable income among the various tax 
jurisdictions in which the Company does business.  The effective 
tax rate for the remainder of fiscal 1998 is expected to be 
consistent with the rate for the first nine months.  

Net income of $21.1 million increased $2.0 million or 11%, from 
the first three quarters of fiscal 1997.  Basic earnings per 
share grew $.25, or 16%, to $1.83 compared with $1.58 for the 
same period last year.  Diluted earnings per share increased by 
$.23, or 15%, to $1.72 compared with $1.49 reported for the first 
nine months of the prior year.  Basic and diluted earnings per 
share were favorably impacted by the Company's stock repurchase 
program.

Liquidity and Capital Resources

The Company's liquidity and capital resources remained strong 
during the first nine months of fiscal 1998.  At March 31, 1998, 
the Company had cash and cash investments of $23.9 million.

During the third quarter of fiscal 1998, the Company repurchased 
259,275 shares of its common stock, bringing the total shares 
repurchased for the first nine months of fiscal 1998 to 633,225.  
During fiscal 1997, the Company repurchased a total of 791,739 
shares of its common stock.

At March 31, 1998, the Company's Japanese subsidiary had utilized 
$750,000 of the $14.2 million available to the Company under its 
committed bank lines of credit.  The Company believes that its 
cash flow from operations, its existing cash and cash investments 
and unutilized portion of its bank lines of credit will be 
adequate to meet its cash requirements for the remainder of the 
fiscal year.    

The impact of inflation on Dionex Corporation's financial 
position and results of operations was not significant during the 
nine months ended March 31, 1998.  

















13
<PAGE>
Except for historical information contained herein, the above 
discussion contains forward-looking statements within the meaning 
of Section 27A of the Securities Act of 1933, as amended, Section 
21E of the Securities and Exchange Act of 1934, as amended, and 
the Private Securities Litigation Reform Act of 1995, and are 
made under the safe harbor provisions thereof.  Such statements 
are subject to certain risks and uncertainties that could cause 
actual results to differ materially from those discussed here.  
Such risks and uncertainties include: general economic 
conditions, foreign currency fluctuations, competition from other 
products, new product development, including market 
receptiveness, existing product obsolescence, fluctuation in 
worldwide demand for analytical instrumentation, the ability to 
manufacture products on an efficient and timely basis and at a 
reasonable cost and in sufficient volume, the ability to attract 
and retain talented employees and other risks as described in 
more detail in the Company's Form 10-K.  Readers are cautioned 
not to place undue reliance on these forward-looking statements 
which reflect management's analysis only as of the date hereof.  
The Company undertakes no obligation to publicly release the 
results of any revision to these forward-looking statements which 
may be made to reflect events or circumstances after the date 
hereof or to reflect the occurrence of unanticipated events.  


































14
<PAGE>
                    PART II.  OTHER INFORMATION



Item 6.  Exhibits and Reports on Form 8-K

         (a)  The following exhibits are filed with the Company's
              Form 10-Q:

    Exhibit        Description

      2.7          Financial Data Schedule for the
                   period ended March 31, 1998

(b)  The Company did not file any reports on Form 8-K during
     the quarter ended March 31, 1998.


SIGNATURES 



PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, 
THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF 
BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.


                            DIONEX CORPORATION
                            (Registrant)


Date: May 11, 1998 	        By:/s/ A. Blaine Bowman
                               A. Blaine Bowman
                               President, Chief Executive
                               Officer



                            By:/s/ Michael W. Pope
                               Michael W. Pope
                               Vice President, Finance and
                               and Administration
                               (Principal Financial and 
                                Accounting Officer)













15


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
condensed consolidated financial statements included in the Form 10-Q of Dionex
Corporation for the quarter ended March 31, 1998 and is qualified in its
entirety by referenced to such financial statements.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1000
       
<S>                             <C>                     <C>                     <C>                     <C>
<C>
<PERIOD-TYPE>                   9-MOS                   6-MOS                   3-MOS                   9-MOS
6-MOS
<FISCAL-YEAR-END>                          JUN-30-1998             JUN-30-1998             JUN-30-1998             JUN-30-1997
             JUN-30-1997
<PERIOD-END>                               MAR-31-1998             DEC-31-1997             SEP-30-1997             MAR-31-1997
             DEC-31-1996
<CASH>                                           19004                   21741                   18745                   23590
                   16359
<SECURITIES>                                      4850                    6902                    6702                    6252
                    9252
<RECEIVABLES>                                    31652                   30115                   29013                   30003
                   29038
<ALLOWANCES>                                       548                     502                     473                     433
                     505
<INVENTORY>                                       9771                    9396                   10517                    8900
                    8301
<CURRENT-ASSETS>                                 74143                   76665                   73187                   76533
                   70775
<PP&E>                                           46143                   45881                   45684                   45849
                   45072
<DEPRECIATION>                                   16709                   16193                   15830                   15332
                   15004
<TOTAL-ASSETS>                                  112348                  115815                  112709                  113823
                  108331
<CURRENT-LIABILITIES>                            31486                   31684                   30910                   31118
                   29075
<BONDS>                                              0                       0                       0                       0
                       0
                                0                       0                       0                       0
                       0
                                          0                       0                       0                       0
                       0
<COMMON>                                         39244                   36259                   36211                   36051
                   32703
<OTHER-SE>                                       38929                   44877                   42497                   44841
                   44482
<TOTAL-LIABILITY-AND-EQUITY>                    112348                  115815                  112709                  113823
                  108331
<SALES>                                         111757                   73353                   33933                  104754
                   68108
<TOTAL-REVENUES>                                111757                   73353                   33933                  104754
                   68108
<CGS>                                            35254                   23120                   10767                   31782
                   20738
<TOTAL-COSTS>                                    35254                   23120                   10767                   31782
                   20738
<OTHER-EXPENSES>                                     0                       0                       0                       0
                       0
<LOSS-PROVISION>                                     0                       0                       0                       0
                       0
<INTEREST-EXPENSE>                                  81                      54                      41                      66
                      48
<INCOME-PRETAX>                                  31974                   20583                    8801                   29108
                   18395
<INCOME-TAX>                                     10871                    6998                    2992                   10043
                    6346
<INCOME-CONTINUING>                              21103                   13585                    5809                   19065
                   12049
<DISCONTINUED>                                       0                       0                       0                       0
                       0
<EXTRAORDINARY>                                      0                       0                       0                       0
                       0
<CHANGES>                                            0                       0                       0                       0
                       0
<NET-INCOME>                                     21103                   13585                    5809                   19065
                   12049
<EPS-PRIMARY>                                     1.83                    1.17                     .50                    1.58
                     .99
<EPS-DILUTED>                                     1.72                    1.10                     .47                    1.49
                     .94
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission